The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.

<h4>Background</h4>Onchocerciasis ("river blindness") can cause severe morbidity, including vision loss and various skin manifestations, and is targeted for elimination using ivermectin mass drug administration (MDA). We calculated the number of people with Onchocerca volvulus...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natalie V S Vinkeles Melchers, Wilma A Stolk, Welmoed van Loon, Belén Pedrique, Roel Bakker, Michele E Murdoch, Sake J de Vlas, Luc E Coffeng
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/b513b8d560024ee0a8ebb56d338e43fc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b513b8d560024ee0a8ebb56d338e43fc
record_format dspace
spelling oai:doaj.org-article:b513b8d560024ee0a8ebb56d338e43fc2021-11-25T06:33:28ZThe burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.1935-27271935-273510.1371/journal.pntd.0009604https://doaj.org/article/b513b8d560024ee0a8ebb56d338e43fc2021-07-01T00:00:00Zhttps://doi.org/10.1371/journal.pntd.0009604https://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>Onchocerciasis ("river blindness") can cause severe morbidity, including vision loss and various skin manifestations, and is targeted for elimination using ivermectin mass drug administration (MDA). We calculated the number of people with Onchocerca volvulus infection and onchocercal skin and eye disease as well as disability-adjusted life years (DALYs) lost from 1990 through to 2030 in areas formerly covered by the African Programme for Onchocerciasis Control.<h4>Methods</h4>Per MDA implementation unit, we collated data on the pre-control distribution of microfilariae (mf) prevalence and the history of control. Next, we predicted trends in infection and morbidity over time using the ONCHOSIM simulation model. DALY estimates were calculated using disability weights from the Global Burden of Disease Study.<h4>Results</h4>In 1990, prior to MDA implementation, the total population at risk was 79.8 million with 26.0 million (32.5%) mf-positive individuals, of whom 17.5 million (21.9%) had some form of onchocercal skin or eye disease (2.5 million DALYs lost). By 2030, the total population was predicted to increase to 236.1 million, while the number of mf-positive cases (about 6.8 million, 2.9%), people with skin or eye morbidity (4.2 million, 1.8%), and DALYs lost (0.7 million) were predicted to decline.<h4>Conclusions</h4>MDA has had a remarkable impact on the onchocerciasis burden in countries previously under the APOC mandate. In the few countries where we predict continued transmission between now and 2030, intensified MDA could be combined with local vector control efforts, or the introduction of new drugs for mopping up residual cases of infection and morbidity.Natalie V S Vinkeles MelchersWilma A StolkWelmoed van LoonBelén PedriqueRoel BakkerMichele E MurdochSake J de VlasLuc E CoffengPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 15, Iss 7, p e0009604 (2021)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Natalie V S Vinkeles Melchers
Wilma A Stolk
Welmoed van Loon
Belén Pedrique
Roel Bakker
Michele E Murdoch
Sake J de Vlas
Luc E Coffeng
The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
description <h4>Background</h4>Onchocerciasis ("river blindness") can cause severe morbidity, including vision loss and various skin manifestations, and is targeted for elimination using ivermectin mass drug administration (MDA). We calculated the number of people with Onchocerca volvulus infection and onchocercal skin and eye disease as well as disability-adjusted life years (DALYs) lost from 1990 through to 2030 in areas formerly covered by the African Programme for Onchocerciasis Control.<h4>Methods</h4>Per MDA implementation unit, we collated data on the pre-control distribution of microfilariae (mf) prevalence and the history of control. Next, we predicted trends in infection and morbidity over time using the ONCHOSIM simulation model. DALY estimates were calculated using disability weights from the Global Burden of Disease Study.<h4>Results</h4>In 1990, prior to MDA implementation, the total population at risk was 79.8 million with 26.0 million (32.5%) mf-positive individuals, of whom 17.5 million (21.9%) had some form of onchocercal skin or eye disease (2.5 million DALYs lost). By 2030, the total population was predicted to increase to 236.1 million, while the number of mf-positive cases (about 6.8 million, 2.9%), people with skin or eye morbidity (4.2 million, 1.8%), and DALYs lost (0.7 million) were predicted to decline.<h4>Conclusions</h4>MDA has had a remarkable impact on the onchocerciasis burden in countries previously under the APOC mandate. In the few countries where we predict continued transmission between now and 2030, intensified MDA could be combined with local vector control efforts, or the introduction of new drugs for mopping up residual cases of infection and morbidity.
format article
author Natalie V S Vinkeles Melchers
Wilma A Stolk
Welmoed van Loon
Belén Pedrique
Roel Bakker
Michele E Murdoch
Sake J de Vlas
Luc E Coffeng
author_facet Natalie V S Vinkeles Melchers
Wilma A Stolk
Welmoed van Loon
Belén Pedrique
Roel Bakker
Michele E Murdoch
Sake J de Vlas
Luc E Coffeng
author_sort Natalie V S Vinkeles Melchers
title The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
title_short The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
title_full The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
title_fullStr The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
title_full_unstemmed The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
title_sort burden of skin disease and eye disease due to onchocerciasis in countries formerly under the african programme for onchocerciasis control mandate for 1990, 2020, and 2030.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/b513b8d560024ee0a8ebb56d338e43fc
work_keys_str_mv AT natalievsvinkelesmelchers theburdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT wilmaastolk theburdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT welmoedvanloon theburdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT belenpedrique theburdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT roelbakker theburdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT micheleemurdoch theburdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT sakejdevlas theburdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT lucecoffeng theburdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT natalievsvinkelesmelchers burdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT wilmaastolk burdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT welmoedvanloon burdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT belenpedrique burdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT roelbakker burdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT micheleemurdoch burdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT sakejdevlas burdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
AT lucecoffeng burdenofskindiseaseandeyediseaseduetoonchocerciasisincountriesformerlyundertheafricanprogrammeforonchocerciasiscontrolmandatefor19902020and2030
_version_ 1718413641336750080